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Benzene and 13 potential metabolites were investigated forgenotoxicity in Salmonella typhimurium and
V79 Chinese hamstercells. In the presence ofNADPH-fortifiedhepatic postmitochondrial fraction (S9 mix),
benzene reverted his- S. typhimurium strains. The effect was strongest in strain TA1535. Among the poten-
tial metabolites, onlythe trans-1,2-dihydrodiol, inthepresence ofS9 mix, andthe diolepoxides, inthepresence
and absence ofS9 mix, proved mutagenic in this strain. The anti-diol epoxide was more potent than thesyn-
diastereomer. Both enantiomers ofthe anti-diastereomer showedsimilar activities. S9 mix did not appreciably
affect the mutagenicity ofthe anti-diol epoxide. However, detoxification was observedwhenpurified rat liver
dihydrodiol dehydrogenase (EC 1.3.1.20) was used at concentrations comparable to thatpresent in the liver.
The (1S)-anti-diol epoxide was a much better substrate than the (1R)-enantiomer, as was true also for(iS)-
versus (1R)-trans-1,2-dihydrodiol. The anti-diol epoxide reverted all six strains ofS. typhimurium used and
induced all four genotoxic effects studied in V79 cells (sister chromatid exchange > acquisition of
6-thioguanine resistance, acquisition ofouabain resistance, micronuclei). However, otherpotential benzene
metabolites showed genotoxic effects in V79 cells, as well: sister chromatid exchange was induced by the
syn-diol epoxide, 1,2,4-trihydroxybenzene, hydroquinone, catechol, and 1,2,3-trihydroxybenzene. Elevated
frequencies of micronucleated cells were observed after treatment with hydroquinone, 1,2,4-trihy-
droxybenzene, catechol, phenol, 1,2,3-trihydroxybenzene, and quinone. Mutations to 6-thioguanine resis-
tance were induced by quinone, hydroquinone, 1,2,4-trihydroxybenzene, catechol, and the trans-1,2-dihy-
drodiol. Byfarthe mostprominenteffect inthe whole study was thepotentinduction ofgene mutations by
quinone and hydroquinone. Quinone produced an approximately 100-fold increase in the frequency
6-thioguanine-resistant cells even ataconcentration of1MM. This effectwas surprising, sincebenzoquinone
induced almost no mutations in S. typhimurium. In the V79 cells, it did not induce mutations to ouabain
resistance and sister chromatid exchange, and it induced micronuclei with moderate efficiency only. This
unique and narrow spectrum ofgenotoxic activities differs fromthebroad spectrum observed with the anti-
diol epoxide, suggesting qualitative differences in their interaction with genetic material.
Introduction
Substantial evidence has accumulated onthe important
role mutations play in chemical carcinogenesis. This is
true inparticular for a number ofcarcinogenicpolycyclic
aromatic hydrocarbons (1). Epoxides, especially vicinal
diol epoxides, appearto constitute theirmajormutagenic
metabolites (1,2). Such epoxides are carcinogenic (1),
transform cells in culture (3,4), and induce a wide spec-
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trum ofmutations(1,2,5), includingthe reversion ofaux-
otrophic bacteria, the acquisition of resistance toward
toxic chemicals, and the activation of oncogenes.
Unlike the casewithpolycyclicaromatichydrocarbons,
the evidenceforarole formutationsisweakwiththe car-
cinogen benzene. Heritable functional changes (termed
gene mutations inthepresent study)wereusually not ob-
servedinbacteriaand mammalian cellstreatedwithben-
zene orbenzene metabolites (6). However, chromosomal
damage was detectedby means ofcytogenetictechniques
(6-13). Interestingly, the metabolites that showed this
genotoxic activity were not epoxides, but were poly-
hydroxylated metabolites (catechol, hydroquinone,
1,2,4-trihydroxybenzene) and quinones (9-13).
Thesefindings suggestthatbenzene andpolycyclic aro-
matichydrocarbons differinthe chemicalnature aswellGLATT ETAL.
as in the biological activities oftheir active metabolites.
Nevertheless, the following points should prevent us
from overemphasizingthese differences: a)The doses of
benzenerequiredforcarcinogenesis arehigherbyseveral
orders ofmagnitude thanthose required withpolycyclic
aromatic hydrocarbons. Very minor metabolites and/or
metabolites of relatively weak biological activity could
therefore be responsible for benzene carcinogenesis; b)
only very fewbiochemical andtoxicological studies have
been conducted onbenzene oxides, dihydrodiols, and diol
epoxides, the structural analogues ofthe critical metabo-
lites ofpolycyclic aromatichydrocarbons; and c)in short-
term tests with benzene, its high volatility may pose a
problem, rendering standard methods insensitive.
In the past decade, we have studied intensively the
mutagenicity of metabolites of polycyclic aromatic
hydrocarbons and their enzymatic control (2). We in-
cluded benzene metabolites sporadically inthese studies.
Benzene and trans-benzene-1,2-dihydrodiol showed muta-
genic activity in S. typhimurium when ahepaticenzyme
system was present. Systematic mutagenicity studies
were initiated when benzene-1,2-diol 3,4-oxides became
synthetically available (14). Knowing the clastogenic ac-
tivity ofpolyhydroxylated metabolites, it was ofpartic-
ular interest to examine whether multiple activation
pathways exist for benzene and whether the genotoxic
metabolites differ qualitatively in their effects. This re-
quiredthat severalgenotoxic effects could be determined
in the same target cell system, since otherwise differ-
ences in responses could be interpreted as the result of
trivial differences between cells, e.g., inactivation, detox-
ification, orrepair. Chinese hamsterV79 cells were apar-
ticularly suitable experimental model, since one could
study atthe same time the inductions ofgene mutations
(to ouabain and 6-thioguanine resistance), sister chro-
matid exchange (SCE), and micronuclei.
The structures ofthe compounds studied are shown in
Figure 1. All compounds, exceptduroquinone (whichwas
used for mechanistic reasons), the diol epoxides (which
have notyet beenavailable asstandards inanymetabolic
studies) and 1,2,3-trihydroxybenzene (an oxidation-
sensitive isomer of 1,2,4-trihydroxybenzene) are known
metabolites of benzene, observed at least in certain in
vitro systems. Muconaldehyde, a reactive metabolite of
benzenethatwasrecently detected (15), was notavailable
forthis study. Also notinvestigated were the conjugated
benzene metabolites and muconic acid.
Mutagenicity in Salmonella
typhimurium
Unlike other reports in the literature (16-20), we ob-
served apositiveresponse ofbenzene in S. typhimurium.
The major methodological difference was that in the
earlier studies the conventional plate-incorporation and
preincubation protocols were used, whereaswe exposed
the bacteria to benzene vapor in desiccators. This tech-
nique allows much longer exposure periods than is pos-
sible forhighlyvolatile compounds with conventional pro-
tocols.
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FIGURE 1. Structures and metabolic relations ofthe investigated com-
pounds. Full and dashed arrows indicate established and hypotheti-
cal metabolic pathways, respectively. Enantiomeric aspects are not
implied in the structures. Some benzene metabolites maybe formed
on additional routes, e.g., the catechol possibly through further
hydroxylation ofthephenol. The syn-diol epoxide isthe diastereomer
in which theallylic hydroxylgroup and the oxirane moiety are on the
same face ofthe benzene ring, whereas thesegroups are on opposite
faces in the anti-diol epoxide.
Mutagenicity ofbenzene wasobserved only in thepres-
ence, but not in the absence, of NADPH-fortified post-
mitochondrial fraction (S9 mix)from rat andmouse liver
homogenate (Fig. 2). The most responsive strain was
TA1535. A 2-fold increase in the number of mutants
above controlwas observedevenatabenzene concentra-
tion as low as 10ppm. However, furtherincreases in the
concentrationhadonly amodesteffect. Themaximalmu-
tant number was about 3-fold the values for the control
plates. Similareffectswerethen seenoverawide concen-
tration range, with the limitation that details of the
concentration-response curve may have been over-
shadowedbytheunfavorableratio ofeffectandvariation.
For this same reason, it was impossible to detect quan-
titative differences in effect between the various
metabolizing systems used. It would be very difficult,
therefore, to elucidate the activation mechanism by
studying the effect of modulations of the metabolizing
system.
Benzene oxide, tested only in the absence ofliver S9
mix, did not show mutagenicity in a study conducted in
ourlaboratory (21). Apositiveresultin strain TA100was
reportedforbenzene oxidewhen highconcentrations(-
7.1 mM) were used in a preincubation assay (22). How-
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FIGURE 2. Mutagenicity of benzene in Salmonella typhimurium
TA1535 in the presence of mouse and rat liverpostmitochondrial su-
pernatant (S9) preparation. Agarplates, containing bacteria (about
108 colony forming units) and the liver preparation in an agar over-
lay, were replaced for 18 hrin a desiccatorwith benzene. Afterfur-
ther incubation for 2 days in the dark in the absence ofbenzene at
370C, the colonies were counted. Each type ofsymbol represents a
separate set of experiments, the individual symbol represents the
mean number ofcolonies from two plates. Hepatic S9 fractions were
prepared from male Sprague-Dawley rats(closed symbols) orfemale
C57BL mice (open symbols) that had received a single IP injection
ofAroclor 1254, 500mg/kgbodyweight, 6dayspreviously. Each in-
cubation contained S9 fraction equivalent to 50 mg(V) or 100 mg liver
(other symbols) and the following cofactor systems: 2 jmole NADP+
and 2.5M*mole glucose 6-phosphatel(V), or20Mmole NADI, 10Mmole
NADP+, and 5 Mmole glucose 6-phosphate (other symbols). The
parameters ofthe assay not specifically mentioned were as described
previously (30).
ever, the positive result essentially depended on misin-
terpretation of the data, involving the use of an inap-
propriate method for the correction for cytotoxicity (23).
Except for benzene oxide and the syn-diol epoxide, all
benzene derivatives were investigated formutagenicity
in the presence and absence ofrat liver S9 mix(Table 1).
InTA1535, the strain showingthe strongest responsefor
bioactivated benzene, only trans-benzene-1,2-dihydrodiol
(Fig. 3) and the diol epoxides (Fig. 4) proved positive.
Mutagenicity of the trans-1,2-dihydrodiol required the
presence of ahepaticmetabolizing system(Fig. 3). Cyto-
solic dihydrodiol dehydrogenase converts the
trans-1,2-dihydrodiol to catechol (24-26), otherwise vir-
tually nothing is known about the metabolic fate of the
trans-1,2-dihydrodiol. The catechol was not mutagenic
either in the presence or in the absence ofliver S9 mix
(Fig. 3)and, therefore, could not account for the S9 mix-
mediated mutagenicity of the trans-1,2-dihydrodiol.
Moreover, the cytosol was notrequiredforthe activation
of the dihydrodiol, as shown in experiments where the
postmitochondrial fraction was substituted by a
microsomal preparation (data not shown).
The kinds ofreactions that may occur in such a system
appear to be very limited. In fact, the only precedent is
the metabolism of dihydrodiols derived from polycyclic
aromatic hydrocarbons to diol epoxides (1,2). The idea
that diol epoxides are the mutagenic metabolites formed
fromthe trans-1,2-dihydrodiol isfurthersupported bythe
response spectra in the series ofbacterial strains used.
For the trans-1,2-dihydrodiol and the diol epoxides (as
well as for benzene) the order of responsiveness was
TA1535 > TA100 > TA98 (with the other strains the
dataare incomplete). Two diastereomers ofthe diol epox-
ides are possible, depending on which face of the
trans-1,2-dihydrodiol the epoxide group is introduced. In
strain TA1535, bioactivated trans-1,2-dihydrodiol, syn-
diol epoxide, and anti-diol epoxide induced about 12,20,
and800revertants per ,umole oftest compound. In afirst
approximation, 60 and 1.5% of the trans-dihydrodiol
wouldtherefore have tobe converted to the syn-diol and
anti-diol epoxide, respectively, ifthis were the only ac-
tivemetabolite. Itistherefore reasonable to suspectthat
at least some anti-diol epoxide is formed.
trans-Dihydrodiols and diol epoxides are chiral mole-
cules. For the anti-diol epoxides, we synthesized the in-
dividual enantiomers separately. In all six bacterial
strainsused, themutagenicpotencies werevirtually iden-
tical for both enantiomers (data not shown).
Whereas in strain TA1535 only benzene, the trans-
1,2-dihydrodiol, and the diol epoxides showed mutagenic
effects, positive results were observedforadditionalben-
zene derivatives in other strains (Table 1). 1,2,3-Trihy-
droxybenzene, whose metabolic formation has not yet
been observed, showed relatively potent effects in
several strains..1,2,4-Trihydroxybenzene, a minor
metabolite ofbenzene, was mutagenic in strainTA104in
the presence of liver S9 mix. With hydroquinone, qui-
none, and catechol, small increases, intherange ofthe de-
tection limit, in the number ofmutants were frequently
observed. While webelieve inthe reality ofthese effects,
their usefulness in the elucidation of the activation
mechanisms ofbenzene may be negligible.
Benzene Dihydrodiols and
Diol Epoxides As Substrates of
Dihydrodiol Dehydrogenase
Many metabolites ofpolycyclic aromatic hydrocarbons
do not appear to be carcinogenic, although they are po-
tent mutagens in S. typhimurium (2). One of the addi-
tional prerequisites forappreciable carcinogenicity is re-
sistance to detoxification (2). (1R)- as well as (1S)-anti-
benzene-diol epoxide showed similar mutagenic activity
in thepresence and absence ofrat liver S9 mix(datanot
shown). However, inbacterialmutagenicity assaysthe S9
enzymes are present in strongly diluted form, as com-
pared to the liver. In the experiments with the benzene
metabolites, including the diol epoxides, we normally
used S9 fraction equivalent to 17 mg liver in an incuba-
tion volume of620pL. In aprevious mutagenicity study
we showedthat diolepoxides derivedfrompolycyclic aro-
matichydrocarbonsmaybe detoxified inmutagenicity as-
saysbypurifiedratliverdihydrodiol dehydrogenase (27).
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Table 1. Mutagenicity ofbenzene and potential metabolites in Salmonella typhimurium.a
Compound
Benzene
Benzene oxide'
Phenol
Hydroquinone
Quinone
2,2'-Dihydroxybiphenyl
4,4'-Dihydroxybiphenyl
(±)-trans-1,2-Dihydrodiol
Catechol
(±)-syn-Diol epoxide
(1R)-anti-Diol epoxide
(1S)-anti-Diol epoxide
1,2,4-Trihydroxybenzene
1,2,3-Trihydroxybenzene
Dose range tested,
S9 l.g/plate
- 3-1000 ppmd
+ 3-1000 ppmd
- 20-4000
- 100-5000
+ 20-5000
- 1.25-40
+ 50-1000
- 0.125-4
+ 10-200
- 20-1000
+ 20-1000
- 20-1000
+ 20-1000
- 10-3000
+ 3.15-3000
- 50-1000
+ 50-5000
- 10-315
- 10-320
- 10-320
- 2.5-40
+ 1-2000
- 6.25-200
+ 1.25-500
LD50,b
pg/plate
NT
NT
NT
3000
1800
> 40
> 1000
5
70
300
300
1100
> 1000
NT
NT
380
4000
NT
NT
NT
> 40
2200
> 200
400
ResponseC
TA97
NT
NT
NT
TA98
NT
TA100 TA102
NT
NT
NT
TA104
NT
NT
TA1535
- - - NT NT -
NT - + NT NT +
NT - - NT NT +
_ _ + + + ++
+ + + ++
* * +
+ - + + +_
+ - + - +_
aThe test compound, bacteria and NADPH-fortified postmitochondrial fraction (S9)from liverhomogenate ofAroclor 1254-treated rats(orbuffer),
were preincubated for 20 min at 370C and then added to minimal agar plates. After incubation for 3 days, the colonies were counted. Except for
thepreincubation andthe amountofS9fraction-in the present study the equivalent of17mgliverwas used perplate-details ofthe protocol were
as described in(4). Fortechnical reasons, amodified protocol wasusedforbenzene (exposure in desiccators). Forhistorical reasons, nopreincubation
was made with benzene oxide and trans-1,2-dihydrodiol, and for the S9-mediated experiments with the latter compound, the equivalent of50 mg
liver was used.
bToxicity was determined using his+ mutants as an internal standard (31).
C(++) The colony number at the optimal dose exceeded the value ofthe solvent controls by a factor of >20; (+) 2- to 20-fold (TA1535, TA98) or
1.5- to 10-fold (other strains), increase in colony number at optimal dose; (-) at all dose levels tested, the numbers ofcolonies were less than the
2-fold(TA1535, TA98) or 1.5-fold(other strains) ofthe solvent control values. In some cases(*), our datasuggest the existence ofa weak effectbelow
this criterion. NT, not tested.
dExposure in desiccators; see Fig. 2.
'Data from a previous study (21). Bacteria and test compound were added to plates without a preincubation. Toxicity, in form ofdilution ofthe
his- background lawn, was observed at doses >2000Mg.
fRacemic anti-diol epoxide, at a dose of 1000 ag per plate (which is more than that used with the individual enantiomers), led to a 2-fold increase
in the number of mutants above the value ofthe controls.
With the same protocol, 0.3 units of dihydrodiol de-
hydrogenase, which is the amount ofenzyme present in
120mgliver, reduced themutagenicity ofanti-benzene-
diol epoxide inS. typhimurium TA1535by 17% (incuba-
tion volume = 620 ML); 0.6 units (equivalent to 240 mg
liver)led to areduction of35%, but afurther increase in
the amount ofenzyme to 2.4 units (equivalent to 960mg
liver) showed no additional protective effect. The prod-
uctsformedbydihydrodioldehydrogenasefromanti-diol
epoxide have notyetbeenquantitativelyidentified; how-
ever, formation of 1,2,4-trihydroxybenzene (a nonmuta-
gen in strain TA1535) was observed.
Kinetic analysis in biochemical assays(Table 2) shows
that the racemic anti-diol andsyn-diol epoxides are rela-
tively good substrates. Their VmaxlKmvalues were 5 and
18%, respectively, ofthe value for trans-1,2-dihydrodiol,
which is a good substrate. Dihydrodiol dehydrogenase
may therefore detoxify benzene-diol epoxides by two
mechanisms, sequestration of the metabolic precursor
and inactivation of the already formed diol epoxides.
However, it is noteworthy that only one enantiomer of
trans-benzene-1,2-dihydrodiol and one enantiomerofthe
anti-diol epoxide [inboth cases the (1S) enantiomer] are
good substrates. Unfortunately, it appearsthatthe(1R)-
trans-1,2-dihydrodiol is preferentiallyformed inthe liver
(24). Nevertheless, Billings observed the formation of
catechol frombenzene in isolated hepatocytes viathe di-
hydrodiol pathway (26).
Genotoxicity in Chinese Hamster
V79 Cells
The results from the genotoxicity experiments in V79
cells are summarized in Table 3 (gene mutations to
6-thioguanine resistance), Table 4 (induction of
micronuclei), andTable 5(inductionofSCE). Usuallythe
compounds were tested up to their cytotoxic limits.
(Theselimitsvariedwiththeendpoint. Forthe detection
ofgenemutations, a substantial fraction ofthe cellpopu-
lation has to survive formanygenerations, whereas ini-
tialgrowth retardation isacceptable. Long-term survival
is dispensable forthe cytogenetic assays, but two rounds
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FIGURE 3. Mutagenicity of trans-benzene-1,2-dihydrodiol (0,C) and
catechol-(, O) in Salmonella typhimurium TA1535 in the presence
(closed symbols)andabsence(open symbols)ofNADPH-fortified post-
mitochondrial supernatant (S9) fraction from liver homogenate of
Aroclor 1254-treated male Sprague-Dawley rats. The plate-
incorporation protocol was used and each plate received S9 equiva-
lent to 100 mg liver tissue. Details ofthe assays were as described
previously (4).
ofreplication are required for the detection ofSCE and
at least one cell division is necessary forthe formation of
micronuclei. In the SCE assay, but not in the
micronucleus assay, cellsfulfillingtheserequirements can
be distinguished from other cells, permitting scoring at
higher levels of cytotoxicity.)
2000
1000
500
200
100
50
20
0 315 10 31.5 100
TEST COMPOUND 1ug per plate ]
FIGURE 4. Mutagenicity of anti-benzene-diol epoxide (C) and syn-
benzene-diol epoxide (O) in Salmonella typhimurium TA1535. The
test compound (dissolved in 10ML dimethylsulfoxide:triethylamine,
1000:1), 100ML ofthe bacterial resuspension (1.04 x 108 colony form-
ingunits) and 500MLbuffer(150 mM KCl, 10mM sodium phosphate
buffer, pH 7.4) were incubatedfor20 miin at370C. Soft agar was then
added and the mixture poured onto minimal agar plates (27). After
incubationfor3 days at 370C in the dark, the colonies were counted.
Values are means from two plates, the average standard deviation
being 10.7% of the mean.
Table 2. Benzene dihydrodiols and diol epoxides as substrates ofrat
liver dihydrodiol dehydrogenase.a
Compound VmaxlKm, mL/min/mg protein
trans-1,2-Dihydrodiol
Racemic 2.8
(lS)-Enantiomer 6.0
(lR)-Enantiomer 0.12
anti-Diol epoxide
Racemic 0.14
(lS)-Enantiomer 0.25
(lR)-Enantiomer 0.014
syn-Diol epoxide
Racemic 0.52
aThe enzyme waspurified to apparent homogeneity from ratliver(25).
Activity was determined spectrophotometrically at 370C by following
NADPH production. The assay mixture contained NADP (2.3 mM),
the substrate and Tris-HCl buffer (50 mM, pH 9.0).
First investigated was anti-diol epoxide, the putative
principal active metabolite ofbenzene in the Ames test.
Racemic anti-diol epoxide induced SCE, mutations to
6-thioguanine resistance, as well as micronuclei. Signifi-
cant effects were observed at concentrations of 10, 50,
and 250 MM, respectively. A fourth end point, induction
ofmutations to ouabain resistance, was studiedusing the
individual enantiomers of the anti-diol epoxide. Both
enantiomers showed significant, butweakeffects, asthey
did with regard of 6-thioguanine resistance (data not
shown). The (iR) enantiomer was slightly more active
than the (1S) enantiomer in respect to 6-thioguanine re-
sistance, whereas the reverse was true with respect to
ouabainresistance. Thesyn-diol epoxide was studied for
induction ofSCE andmicronuclei. Ten times higher con-
centrations than ofthe anti-diol epoxide were required
for the equal effect on SCE, whereas an induction of
micronuclei was not observed even at very high concen-
tration ofthe syn-diol epoxide.
Quinone was the most cytotoxic ofall benzene deriva-
tivestested. Muchto oursurprise, itwas apotentinducer
ofgene mutations to 6-thioguanine resistance. Exposure
at aconcentration of1 MM led to a 100-foldincrease inthe
mutationfrequency abovethe control value(from4 to400
x 10-6). At the most effective concentration(1.7MM)itin-
duced 700 mutants per 106cells, which is about 10 times
the effect ofthe anti-diol epoxide at the optimal concen-
tration(400MM). Therefore, ifeffect and exposure concen-
tration are taken into account, the quinone was about
2000 times more potent than the anti-diol epoxide. The
mutagenic activitiy of quinone (410 mutations/106
cells/MuM) was similar to those of some bay-region diol
epoxides derivedfrom polycyclic aromatic hydrocarbons.
Under comparable, but not identical conditions, the anti-
and syn-chrysene-1,2-diol 3,4-oxides and the anti- and
syn-9-hydroxychrysene-1,2-diol 3,4-oxides induced 75, 9,
130, and 18 mutations/106 cells/MM, respectively(4). How-
ever, in contrast to diol epoxides derived frompolycyclic
aromatic hydrocarbons and benzene, quinone did not in-
duce mutations to ouabain resistance. The ratio of the
number ofinduced mutations, resistant to 6-thioguanine
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Table 3. Induction of gene mutations (6-thioguanine resistance) in V79 cells by benzene derivatives.a
Optimal/maximal Mutation frequency above Potencyb (induced mutation
Compound concentration, MM background x 106 frequency x 10611AM
Phenol 4000 < 10 < 0.003
Hydroquinone 3.5 400 110
Quinone 1.7 700 410
2,2'-Dihydroxybiphenyl 1000 < 10 < 0.01
4,4'-Dihydroxybiphenyl 1000 < 10 < 0.01
trans-1,2-Dihydrodiol 8000 10 0.0013
Catechol 25 43 1.7
anti-Diol epoxide 400 74 0.19
1,2,4-Trihydroxybenzene 10 42 4.2
Duroquinone 250 < 10 < 0.04
aMutagenicity was determined as described (32). Briefly, a total of 1.5 x 106 cells and 30 mL medium were put into 15-cm Petri dishes. After 18
hr, the test compound was addedfor24 hr. Thefrequency ofmutants resistant to 6-thioguanine (71g/mL)was determined afteran expressionperiod
of6 days. Each compound was tested at least at 5 concentrations, up to the limits oftoxicity. Column 2 shows the highest concentration at which
sufficient cells survivedforappropriate determination ofthe mutation frequency. Forallmutagens, thiswastheconcentration leadingtothe strongest
increase inthe mutationfrequency. Thisvalue, minus themeanmutationfrequencyofthe solvent controlsoftherespective experiment, are shown
in column 3. The mutation frequency ofthe 37 solvent control cultures of this study varied from 0.0 to 32.0 x 10- with a median of8.7 x 10 -6.
All positive test results were confirmed in repeat experiments. For negative test results the detection limit is shown.
"The effect (column 3) was divided by the concentration (column 2). Note that this measure ofmutagenic activity does not take into account the
stability ofthe test compound, its distribution between cells and medium, and potential nonlinearities in the concentration-response curves.
Table 4. Induction ofmicronuclei in V79 cellsby benzene derivatives.a
Optimal/maximal Frequency of
concentration, micronucleated cells x 103
Compound ,uM above backgroundb
Phenol 4000 35
Hydroquinone 17.5c 88
Quinone 6.7c 27
trans-1,2-Dihydrodiol 4000 3
Catechol 25c 35
anti-Diol epoxide 250 21
syn-Diol epoxide 1000 1
1,2,4-Trihydroxybenzene 25 52
1,2,3-Trihydroxybenzene 50c 32
Duroquinone 50 30
aInduction ofmicronuclei was studied as described (33). Briefly, atotal
of2 x 10' cells and 4 mL medium were put into 6-cm Petri dishes. On
the next day, the test compound was added, whereby at least 5
concentrations were used. 24 hrlater, the cells were harvested, treated
with hypotonic KCl-solution andfixed. AfterstainingwithGiemsa,2000
cells were scored per datapointformicronuclei. In control cultures, the
frequency ofmicro-nucleated cells wasusuallyapproximately 10 x 10-3.
Column 2 shows the concentration which gave the strongest effect or,
withtheinactive compounds(trans-1,2-dihydrodiol andsyn-diol epoxide),
the highest concentration used.
bExcept fortrans-1,2-dihydrodiol and syn-diol epoxide, all values are
considered outside accidental variation.
CHigher concentrations were used; however, the frequency of the
micronucleated cells declined toward the value ofthe solvent controls.
This phenomenon is attributed to the inhibition of cell proliferation.
and ouabain, respectively, was 3 forthepositive control,
N-methyl-N'-nitro-N-nitrosoguanidine, 4 for (1S)-anti-
benzene-diol epoxide, about20for(1R)anti-benzene-diol
epoxide and > 100 for quinone. Furthermore, quinone
did not induce asignificant increase in SCE, andthefre-
quency ofmicronucleated cells was increased by afactor
of only three above spontaneous levels. Thus, quinone
showed amuch narrower spectrum ofgenotoxic activity
in V79 cells, than did the anti-diol epoxide.
Hydroquinone was similar to quinone with regard to
the induction of 6-thioguanine resistance, except that
about three times higher concentrations were required.
Table 5. Induction ofsisterchromatidexchange (SCE) in V79 cells
by benzene derivatives.a
Optimal/maximal Number of SCE per cell
Compound concentration,,AM above background
Phenol 1000 2.2
Hydroquinone 20 3.4t
Quinone 8 2.0
trans-1,2-Dihydrodiol 4000 2.0
Catechol 12.5 5.8t
anti-Diol epoxide 100 15.St
syn-Diol epoxide 1000 10.6t
1,2,4-Trihydroxybenzene 10 7.3t
1,2,3-Trihydroxybenzene 25 3.2*
aInduction ofSCE was studiedasdescribed(33). Into 6cmPetri dishes
were given at the times shown in parentheses: 4 mL medium and 2 x
105 cells(0hr), the testcompound(24 hr), 10MAM5-bromo-2'-deoxyuridine
(25 hr), and 0.2 jAg/mL colcemid (47 hr). Cells were harvested (51 hr),
treated with hypotonic KCl, fixed, and stained using the Hoechst
33258/UV/Giemsaprocedure. A total of30metaphases was scored for
SCE per data point. With all compounds, including those without a
significant effect, the number of SCEs was highest at the highest
concentration with differential staining. The numberofSCEs (mean ±
SD)in the control cultures ofthis study varied from 6.2 ± 2.9 to 8.4 ±
2.6. The t-test was used for statistical analysis.
*Statistically significant, p > 0.05.
tStatistically significant, p > 0.01.
However, hydroquinone was substantially more effective
thanquinoneinthe inductionofmicronuclei. Itwasabet-
ter inducer of SCE as well.
Catechol induced all three genotoxic effects studied.
Themain difference ithadfromits isomer, hydroquinone,
was its low efficiency in the induction of6-thioguanine-
resistant mutants. In its relative activities in the induc-
tion of gene mutations, SCE, and micronuclei, it was
more similar to the anti-diol epoxide than to hydroqui-
none andquinone. Inaddition, itarrestedcellsinthefirst
mitosis(datanotshown). Thiswasthereason itcouldbe
studied onlyatrelativelylowconcentrations inthe SCE
assay.
Phenol and the trans-1,2-dihydrodiol showedverylow
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cytotoxicity. Genotoxic effects were observed only at
very high concentrations. Phenol was a weak inducer of
micronuclei, while the trans-1,2-dihydrodiol led to a slight
increase in the frequency of6-thioguanine-resistant cells.
Itis not known whether these effects were causedbythe
test compound itself, metabolites, or impurities. A very
small amount of metabolites or impurity may be suffi-
cient, since the mutagenic activity ofthe trans-1,2-dihy-
drodiol and the micronucleus-inducing activity ofthe phe-
nol were less than 1% of the activities of the potential
metabolites, catechol and anti-diol epoxide, and hydro-
quinone, respectively.
The minorbenzene metabolites 2,2'-dihydroxybiphenyl,
4,4'-dihydroxybiphenyl, and 1,2,4-trihydroxybenzene did
not show any particularly marked effects. 1,2,4-Trihy-
droxybenzene induced gene mutations and SCE and
micronuclei, the activities being similar to those of
catechol. The dihydroxybiphenyls were much less cyto-
toxic than the monocyclic compounds substituted with
two or three phenolic hydroxyl groups, and in contrast
to these compounds they did notinducegene mutations.
1,2,3-Trihydroxybenzene was studied for induction of
SCE and ofmicronuclei. Inboth systems, it showedposi-
tive responses, which however were weaker than those
of its isomer 1,2,4-trihydroxybenzene.
Duroquinone differs from quinone in that it does not
conjugate withglutathione (28). However, inhepatocytes,
it oxidized glutathione, suggesting that it underwent re-
dox cycling with formation of reactive oxygen (28).
Duroquinone was much less cytotoxic in V79 cells than
was quinone. It did not induce gene mutations with a de-
tection limit that was 10,000 times below the activity of
quinone; however, it increased the frequency of
micronucleated cells.
Conclusions
It has been demonstrated in the present study that
metabolites of benzene can induce heritable functional
changes (gene mutations) in bacterial and mammalian
cells. Moreover, the results of the bacterial mutagenic-
ity experiments provide circumstantial evidence for the
idea that a diol epoxide is formed from benzene and ac-
counts for its mutagenicity. The anti-diol epoxide showed
a broad spectrum ofgenotoxic activities in mammalian
andbacterial cells and was resistant to metabolic detox-
ification, at least as far as the systems operative in the
S9 mix were concerned. Partial detoxification may occur
in tissues with high activity of dihydrodiol de-
hydrogenase, as isthe caseinratliver. However, the(1R)
enantiomer ofthe trans-diol epoxide is arelatively poor
substrate. This is the enantiomer that is expected to be
formed preferentially due to stereoselective metabolism
ofbenzene to the (1R)-trans-1,2-dihydrodiol (24).
After application ofbenzene to animals, ahigh propor-
tionofthe dose canberecoveredin theformofunmetabo-
lizedbenzene, phenol, hydroquinone, catechol, andtheir
conjugates. It is unlikely that these metabolites are
formedfrom a diol epoxide. In contrast, 1,2,4-trihydroxy-
benzene is both a metabolite of benzene and a product
formed from the anti-diol epoxide by dihydrodiol de-
hydrogenase. However, alternative pathwaysforitsfor-
mation, not involving a diol epoxide intermediate, are
conceivable.
While it is obvious that diol epoxides are not major
metabolites in the animal as a whole, the situation may
be different in an individual tissue. For example, in iso-
lated hepatocytes from phenobarbital-treated rats,
trans-1,2-dihydrodiol and catechol, which appeared to be
formed exclusively via the trans-1,2-dihydrodiol, made up
26% ofthe metabolites from benzene (26). This is much
more than the contribution ofcatechol, 1,2,4-trihydroxy-
benzene, and their conjugates to the recovered metabo-
litesinanimal studies. Moreover, there isnorationalefor
the concept that carcinogenesis is evoked by a major
metabolite. This is true in particular forbenzene, which
is less potent by many orders of magnitude than other
carcinogens. Hence, the available data on metabolism ar-
gue neither for nor against apossible role for diol epox-
ides in benzene carcinogenesis. Clarification could be
sought in metabolism and carcinogenicity studies with
authentic diol epoxides andanalytical studies on benzene
using authentic diol epoxide metabolites and nucleoside
adducts as standards.
The diolepoxideswerenotthe onlymutagenicbenzene
derivatives in this study. Even more strikingand impres-
sive were the high activities ofquinone andhydroquinone
in the mutation to 6-thioguanine resistance. Quinone
showed a narrow spectrum ofgenotoxic activities. The
lack ofany appreciable activity in S. typhimurium may
be attributed to toxicokinetic differences from V79 cells.
However, such speculations cannotexplain the lackofin-
duction ofouabain resistance and SCE in the V79 cells.
Resistance to 6-thioguanine usually involves failure of
synthesis, or defect in function, ofthe enzyme hypoxan-
thine phosphoribosyl transferase. Such purely destruc-
tive effects canbe achieved by numerous types ofmuta-
tions, includingbase substitutions, frameshifts, andlarge
deletions. The lack of induction of ouabain resistance
(usually involvingbase substitution) and the weakness of
the cytogenetic effectspoint to an unknown, unusual, and
very selective mechanism forthe quinone mutagenicity.
Another aspect of the mechanism involves the active
species. Quinones are electrophiles andmay undergo ad-
dition reactions with nucleophiles. Furthermore, qui-
nones may be reduced to semiquinone free radicals, e.g.,
through the action of one electron reductases, such as
cytochrome P-450 reductase, an enzyme present in V79
cells (I. Gemperlein, F. Oesch, and H. R. Glatt, unpub-
lished result). The semiquinone could then react with the
target molecule directly or via the formation ofreactive
oxygen species. Duroquinone cannot undergo addition
reactions, butmayundergoredoxcyclingin cellswithfor-
mation ofactive oxygen (28). The lack ofmutagenicity of
duroquinone argues therefore against a role for active
oxygen in the mutagenicity ofquinone. Further support
for this notion is provided in an accompanying paper,
dealingwith the mechanism ofquinone mutagenicity (29).
The potent mutagenicity ofhydroquinone is especially
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noteworthy, as this compound can be directly isolated
from the tissues and urine ofanimals treated with ben-
zene, whereas the evidence forthe formation ofquinone
is only indirect. Hydroquinone and its conjugates form
the second major group ofbenzene metabolites, next to
phenol and its conjugates. Since the chemical reactivity
ofhydroquinone is low, one may suspect that it is meta-
bolically activitated in the V79'cells. Identification ofthe
involved enzyme(s) should be ofthe greatest interest, as
hydroquinone is available in body fluids and tissues of
benzene-treated animals. Hydroquinone was nearly as ef-
fective as quinone inthe inductionof6-thioguanine resis-
tance, but slightly higher doseswererequired. However,
hydroquinone differed initsgenotoxicity fromquinone in
thatitinducedmicronucleiwith amuchhigherefficiency,
and in that inaddition itinduced SCE. Therefore, it does
not appearlikelythat all the effects ofquinone andallthe
effects ofhydroquinone are induced by a single chemical
species.
A further benzene metabolite for which mutagenic ac-
tivity was observed is catechol. Like the hydroquinone,
it induced SCE as well as micronuclei and 6-thioguanine
resistance. However, its effectiveness inthe induction of
6-thioguanine resistance was substantially weaker.
Several additional benzene metabolites showed geno-
toxic effects. These activities, however, were weak, at
least when the potential contribution ofthe compounds
in the benzene metabolism is taken into account. We
would therefore not rank them among the prime candi-
dates for the carcinogenic metabolite(s) of benzene if
genotoxicity isthe essential mechanism. Inthisrespect,
preferential attention shouldbegiventoquinone, hydro-
quinone (with semiquinone as apotential active species),
the anti-diol epoxide, catechol, andperhapsmucondialde-
hyde(15), whichwasnotincluded inthisstudy. Consider-
ing the qualitative differences in genotoxicity and
postulatingtherequirement ofseveral distinctmutations,
it ispossible that differentmetabolites areinvolvedat dif-
ferent stages in benzene-induced carcinogenesis.
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